pittcp3.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

CP3's #machinelearning experts, @walidgellad.bsky.social & @jennyciganic, were part of a team that developed ML models to predict bleeding risk in AFib pts. The models performed better than standard risk scores & even uncovered 🆕risk factors. Read more @AmJCardio www.ajconline.org/article/S000...

submitted 18 hours ago • 0 comments

In a new @JAMAInternalMed editorial, Dr. Michael Incze & CP3's @timandersonmd.bsky.social discuss the importance of patient choice in chronic pain treatment. jamanetwork.com/journals/jam...

submitted 5 days ago • 0 comments

It's #PittDayofGiving! Your generous gift to CP3 supports our mission to make medicines safer and more accessible for everyone. We're especially grateful for gifts that help our students and trainees prepare for their careers. Can you help our mission? giveto.pitt.edu/CP3

submitted 6 days ago • 1 comment

Pharmacies are important vaccination hubs, and🆕study suggests children who get vaccinated in pharmacies may be more likely to get timely well-child visits. With CP3's Dr. Lucas Berenbrok Read more in Health Affairs Scholar: academic.oup.com/healthaffair...

submitted 7 days ago • 0 comments

We used PA Prescription Drug Monitoring Prgrm data to develop a #machinelearning model to predict #overdose risk at individual & community levels. We collaborated w/@cmuhcii to create an interactive dashboard prototype to visualize risk in & between PA zip codes. Read more: arxiv.org/abs/2502.10542

submitted 11 days ago • 0 comments

🆕from @us.theconversation.com, CP3/Pitt Pharmacy faculty Dr. Luke Berenbrok describes why community pharmacies are closing and what to do if your pharmacy is one of them. theconversation.com/why-communit...

submitted 12 days ago • 0 comments

Compared to traditional Medicare, MA was associated w/: ⬇️30-day mortality after alcohol w/d ⬇️30-day readmission rates after alcohol w/d & opioid overdose hospitalizations +/- findings on💊use With CP3's @timandersonmd.bsky.social Read more @JAMAInternalMed link.springer.com/article/10.1...

submitted 12 days ago • 0 comments

A 2019 Medicare opioid safety policy meant to address high-risk opioid prescribing was associated with reductions in initial opioid Rx duration & concurrent multiple-prescriber high-dosage episodes. With CP3's @BryantShuey Read more @JAMAInternalMed jamanetwork.com/journals/jam...

submitted 13 days ago • 0 comments

Our latest newsletter is live! Check out some of our latest papers, chances to hear our faculty speak, and ways to support our mission. centerforpharmaceuticalpolicyprescribing.createsend1.com/t/j-e-wcfkd-...

submitted 13 days ago • 0 comments

CP3 Associate Director Dr. Katie Suda & CP3 alum Dr. Patience Moyo Dow were part of a NASEM committee that found Veterans co-prescribed benzos + opioids had ⬆️risk of death. Read more about the study: www.nationalacademies.org/news/2025/02...

submitted 19 days ago • 0 comments

Today is International Day of Women & Girls in Science, but since half of our people are women, CP3 elevates, promotes, and celebrates women in science every day. Get to know our talented people👇 cp3.pitt.edu/people

submitted 20 days ago • 0 comments

This study examined @WHO recommended National Action Plan post-implementation changes in antibiotic utilization among 38 countries. Authors include @mina-t.bsky.social & CP3's Tate Miner, @CallawayKim4, & @Sudamonas Presented @IDWeekmtg & pub in @OFIDJournal academic.oup.com/ofid/article...

submitted 26 days ago • 0 comments

This study compared measures for identifying dementia and cognitive impairment in older veteran nursing home residents and found consistency & utility among them. With CP3's @TomRadomskiMD pubmed.ncbi.nlm.nih.gov/39890090/

submitted 28 days ago • 0 comments

The HumAn-1 trial is complex, collecting evidence for efficacy of insulin glargine for youth w/T1D in low resource settings. It's a successful collaboration among CP3 researchers, other orgs, & international study staff. Read the study protocol in BMJ Open bmjopen.bmj.com/content/15/1...

submitted 31 days ago • 0 comments

Tomorrow starts #NationalHeartMonth! ✅out recent papers from our folks that help prescribers make more informed decisions for🫀health. jamanetwork.com/journals/jam... jamanetwork.com/journals/jam... www.acpjournals.org/doi/10.7326/...

submitted 31 days ago • 0 comments

This team found3️⃣trajectories of potentially nephrotoxic💊use among older adults with T2 Diabetes. Social & clinical factors were associated with 💊use. With CP3's Dr. Kangho Suh & CP3 alums @Serena_JG & @ihdezdelso More in Pharmacoepidemiology & Drug Safety: onlinelibrary.wiley.com/doi/10.1002/...

submitted 35 days ago • 0 comments

CP3 faculty affiliate, @UPittNursing faculty, & clinician-scientist @SarahMBelcher studies the variety of factors that affect adherence to oral anticancer medications. Learn more about Dr. Belcher & her work👇, & don't miss her seminar 2/21! www.health.pitt.edu/news/bedside...

submitted 39 days ago • 0 comments

Analysis estimates coding inflation rates for MA contracts; payment rates incentivize more intensive coding. ⬆️coding intensity for health plans that were HMOs, provider-owned, large, older, or ⬆️⭐️ratings. @timandersonmd.bsky.social More @ Health Affairs Scholar: academic.oup.com/healthaffair...

submitted 40 days ago • 0 comments

Compound pharmacies help alleviate shortages of GLP-1 Receptor Agonists. CP3 faculty affiliate Dr. Julie Donohue underscores the need for greater clarity & oversight from @US_FDA to inform & protect consumers. More in @JAMAHealthForum jamanetwork.com/journals/jam...

submitted 41 days ago • 0 comments

HHS announces the next 15 drugs to negotiate under Part D! Great to see this progress. Quite a few cancer treatments, which will mean more savings potential than in the first year's drug list (cancer drugs get limited or no rebates today). Good news for taxpayers and Medicare spending!

submitted 45 days ago • 3 comments

Ethics and AI are in the news lately. Our team spends a lot of time thinking about ethics in all stages of AI-based clinical decision support tools. ICYMI: our experts describe how to use human factors to mitigate bias. @walidgellad.bsky.social Read the paper: academic.oup.com/jamia/advanc...

submitted 45 days ago • 0 comments

ICYMI: CP3's @NoahMFeder & Dr. Jing Luo analyzed glucagon prescriptions over time, focusing on periods before and after 2018, when new glucagon products entered the market. Read @Medscape summary of the paper, originally published in @JAMA_current 👇 www.medscape.com/viewarticle/...

submitted 47 days ago • 0 comments

Jan 12 was #NationalPharmacistDay. Pharmacists are always part of Team CP3, and we believe they're key members of a patient's care team. Thank you, pharmacists!

submitted 48 days ago • 0 comments

In a new study, CP3's @jennyciganic & team determined that Anti-CGRP mAbs didn't appear to ⬆️CVD risk compared with onabotulinumtoxinA among Medicare beneficiaries with migraine. Read more @JAMANeuro jamanetwork.com/journals/jam...

submitted 49 days ago • 0 comments

Glucagon is recommended for severe hypoglycemia, yet fill rates are low. A🆕study examined Rx & reimbursement trends in glucagon products before & after introduction of newer products in recent years. With CP3's @NoahMFeder & Dr. Jing Luo Read more @JAMA_current jamanetwork.com/journals/jam...

submitted 54 days ago • 0 comments

CP3's @timandersonmd.bsky.social spoke with @statnews about the PREVENT model, a simpler, less expensive way to predict risk of heart failure. @pittgim.bsky.social @pittdeptofmed.bsky.social www.statnews.com/2024/12/16/h...

submitted 59 days ago • 0 comments

#Pharmacoequity is key to reducing health disparities. To help achieve this goal, Drs. Pranav Patel, Laura Happe, & CP3 alum @UREssien developed a framework to measure RxEquity domains. Read more @amcporg #JMCP www.jmcp.org/doi/10.18553... CP3's RxEquity work: www.cp3.pitt.edu/research/pha...

submitted 60 days ago • 0 comments

We're on break until 2025. Wishing everyone light and peace this holiday season.

submitted 73 days ago • 0 comments

Before we break for the holiday, we’re looking back over another productive year of high impact research that improves patient care & medication access. Our incredible team hit the ground running in January & hasn’t stopped yet! 1/7

submitted 74 days ago • 1 comment

New pub from CP3's Dr. Bernie Good 👇

submitted 76 days ago • 0 comments

Great to see CP3 Directors @walidgellad.bsky.social & Dr. Katie Suda featured several times in this issue!

submitted 77 days ago • 0 comments

Join us for the next DGIM Grand Rounds! Dr. Madeleine Lipshie-Williams will present Psychiatry in Primary Care on 12/10/24, 9–10 AM. Don’t miss this opportunity to explore the intersection of #MentalHealth and #PrimaryCare. 💻 DM us for the Zoom link.

submitted 77 days ago • 0 comments

GERD is a common condition that sometimes presents in uncommon ways. Dr. Vikram Rangan & CP3's @timandersonmd.bsky.social discuss how to diagnose & care for these patients. Read more @AnnalsofIM www.acpjournals.org/doi/10.7326/... @pittgim.bsky.social @pittdeptofmed.bsky.social

submitted 77 days ago • 0 comments

Though the US spends more than Canada on 💊purchases, that doesn't translate to better access. Read more @amcporg www.jmcp.org/doi/10.18553... @mina-t.bsky.social @pittgim.bsky.social @pittdeptofmed.bsky.social

submitted 81 days ago • 0 comments

Among pregnant people w/opioid use disorder, longer duration & higher dose of buprenorphine were associated with ⬆️odds of postpartum bupe continuation & not associated w/adverse neonatal outcomes. w/CP3's @jennyciganic & Dr. Julie Donohue Read more @AJOG_thegray www.ajog.org/article/S000...

submitted 84 days ago • 0 comments

Achievement unlocked: We have CP3 gear! Now it's easier to identify CP3 folks in the wild. We were lucky enough to get a few of our people together for a photo today!

submitted 87 days ago • 0 comments

ICYMI: APhA & @pittpharmacy have released interactive maps to, in the words of CP3's Dr. Luke Berenbrok "expand equitable access to vaccinations." Read more @hmebusiness: hme-business.com/apha-univers...

submitted 87 days ago • 0 comments

🚨 New paper alert! Does paying more for drugs in the US mean you’re getting more valuable drugs? The US gets more drugs and gets them sooner, but is the value there? @pittcp3.bsky.social 👉 Read it here: www.jmcp.org/doi/10.18553... #healthpolicy #DrugPricing

submitted 88 days ago • 0 comments

🆕in @NEJMEvidence: CP3's @TimAndersonMD & coauthors discuss what "tomorrow's trial" of inpatient BP management should look like & challenges in conducting it. evidence.nejm.org/doi/full/10.... @pittgim.bsky.social @pittdeptofmed.bsky.social

submitted 88 days ago • 0 comments

This #GivingTuesday, please consider making a donation to CP3. 100% of your donation goes toward our mission of making medications safer and more accessible to all. giveto.pitt.edu/CP3

submitted 90 days ago • 0 comments

CP3 Associate Director Dr. Katie Suda is learning from past #drugshortages to help mitigate future ones. take a look at her most recent paper comparing US vs Canada. jamanetwork.com/journals/jam...

submitted 91 days ago • 0 comments

🆕from @LilyBessette & CP3's @TimAndersonMD - a third of patients eligible for weight loss 💊would have been excluded from their clinical trials. Read more @JAMAInternalMed jamanetwork.com/journals/jam...

submitted 97 days ago • 0 comments

🆕analysis shows most VA facilities have resources for & are conducting recommended tests to identify carbapenem-resistant 🦠. With CP3's aptly-named @Sudamonas. Read more @ASHE_Journal: pmc.ncbi.nlm.nih.gov/articles/PMC...

submitted 97 days ago • 0 comments